Business Context and Reporting Period
Company: Daré Bioscience, Inc. (DARE)
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2026
Event: Regulation FD Disclosure regarding a corporate presentation furnished as Exhibit 99.1. The presentation is intended for use in meetings with securities market participants.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a corporate presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial position or operations are detailed within the text of this 8-K filing. The document references a corporate presentation for further details but does not summarize those contents.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the attached corporate presentation in various meetings with securities market participants commencing September 9, 2026.
Availability: A copy of the presentation is available on the Company's website under the "Investors" section, specifically on the "Presentations, Events & Webcasts" page.
Legal Disclaimer: Information contained in the presentation and the Company's website is not incorporated by reference into this report and is not deemed "filed" under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the contents of the corporate presentation (Exhibit 99.1) for specific operational updates, as the 8-K text itself contains no financial data.
- Confirm the presentation is accessible via the Company's investor relations website at https://ir.darebioscience.com.
- Note that the presentation materials are not legally incorporated by reference into this filing.
- Review the presentation for any forward-looking statements or guidance, as these are not summarized in the 8-K text.